Member Info for Heimdal

Bignose, stock broking is good honest work, do you have a problem with brokers? Heimdal

Sure Bignose, RPG will exit (in due course) but VXR is only 18mth away from production..
I very much doubt we will subscribe for more shares though.

Did you see the 3,350,000 BUY order just before close from JP Morgan @ 18.9c - only partly filled.

10k "golden finger" back in action on close with a 10k BUY @ 19.4c at 15:59:31.

Heimdal

Interesting comment by Irotschild wrt VXR/RegPac on hotcopper this am:

"Regent Pacific's core holdings of 23,849,445 shares remain untouched. They are the foundation shareholders and I believe they paid about $1.35 per share back in 2010/2011. I think they got the Sulphur Springs project right, but the timing was off as the previous cycle fizzled out before VXR could get the mine approved back in the day. Still plenty of meat on the bone if they participate in the 1 for 7. Perhaps holding on for a block trade at $2 or $3 in due time?

The recent share sales are predominantly by the director's private holdings and I believe these are well in the money as he participated in a few previous placements. I reckon the Director is just cashing some chips to spread around other stocks. A number of these are also doing pretty well as I have been following the money trail.

The market seem to welcome the liquidity as the share sales are easily absorbed."

If the exit plan is indeed $2-3 then we could be making another $50,000,000 on this LT investment. Let's see how this plays out but the timing is perfect for Cu with mine production not far away now.

Regent Pacific's MCap is currently just US$58.1m or HK$ 451m with our VXR holding worth HK$ 59,387,483 (13% of the MCap).

Heimdal

Thanks Italian. A bit disappointing as we are falling behind on the news flow front:

Confirmation of Macao launch (March)
Confirmation of Taiwan launch (April)
Confirmation of China clinical trial start (April-May)
USA marketing study news (May)
News on OTC roll out in EU (June)
Potential news on USA partner ahead of Phase III
Confirmation of USA Phase II study submission (first half of 2021)
News on Japan progress
Potential news on LATAM, India and Middle East commercial strategic partners
DLI market update

This indicate that the market update in May will be substantial and should include the
first 4-5 points, possibly more, and as such it should have a significant impact on the share price.
May is just around the corner so sit tight fellas, maybe a good time to top up at these cheap levels?

Heimdal

Dougie, 210,256 users just look at the Young.AI website. Heimdal

Italian, it is a somewhat lengthy article about the blood age feature on Young.AI "Our most favorite aging clock featured on Young.AI is probably BloodAge. It takes in a PDF of a clinical blood test and returns your age. One may wonder, how could that be useful? I already know my age. However, BloodAge prediction is different from your regular, chronological age." It goes on to explain that 46 biomarkers should be present for the most reliable BloodAge predictions, not all of them are equally important though and then list the 10 most important. All in all I think the Young.AI app is a positive development as it should assist people in living more healthy lives. With +190,000 users incl #1 in the UK I hope many users will switch to the more comprehensive version at just $14/month. Heimdal

https://medium.com/longevity-algos/top10-blood-youngai-5bc989f6805e

Heimdal

Dougie, only 2m shares traded yesterday as most traders were probably in holiday mode. Let's see how we go on Wednesday when the punters return.

WRT the ATO issue, not a great concern. US$4.50m due by the end of 2021 (still a long way to go).
In contrast our VXR holding is valued at U$9.4m and we recently received almost US$4m from Wanbang and OEP so I think we will manage in light of the significant 30% cut in salaries which saved us US$2.13m.

Heimdal

Thanks latras, fantastic news :-)

"The Directors are pleased to report that this payment was received, in full, on 31 March 2021.

All efforts will continue to be directed towards commencement of the randomized clinical trial, which remains on track to commence in April / May 2021, with an estimated end point of 12 months thereafter. In this respect and as previously advised, WANBANG Biopharmaceutical has appointed a leading contract research organisation to undertake the phase III double blinded multi-centre randomised clinical trial and the Group looks forward to undertaking this next critical step towards commercialisation of Senstend™ in Mainland China.

If the clinical study meets its endpoints and NMPA has granted an import licence for Senstend™, then US$5 million (or approximately HK$39 million) before deduction of PRC withholding tax will be payable to the Group from Wanbang Biopharmaceutical. In addition, upon first commercial sale of Senstend™ in China, US$2 million (or approximately HK$15.6 million) before deduction of PRC withholding tax shall be payable to the Group from Wanbang Biopharmaceutical. In
addition, the Group will generate low to mid-teens royalties of Wanbang Biopharmaceutical’s net sales of Senstend™ in China. "

Heimdal

Very pleased with the DLI update last night. Jim noted : "We welcome the DLI team into the Group and look forward to achieving milestones and (enjoying commercial success in the near future). Near future Bignose, near future!
Heimdal

I expect we will get the confirmation announcement tonight WRT the HK$25m from Wanbang.
Confirmation of Macao launch also due now, so probably a short announcement tonight or tomorrow.
Heimdal

ENDURANCE is required in order to succeed in life as such the name change is fine with me. It flags an important move into the expanding longevity sector and also makes sense in terms of our world class FORTACIN flagship product.

I note our Chairman Jim Mellon remain very optimistic about the direction the business is taking and in RPG's ability to
generate value for shareholders going forward.

Heimdal

Well worth watching: https://www.youtube.com/watch?v=aVNj-kB8wKM

Heimdal

No DLI market update (as yet), nonetheless it looks like the team is moving forward:

https://www.newscientist.com/article/mg24933260-700-think-yourself-younger-psychological-tricks-that-can-help-slow-ageing/#ixzz6pr5TPxm3

Heimdal

Are you curious to discover your age based on your blood markers, behavioral choices, psychological tests, and your selfie?

With Young.ai, which recently hit the # 1 wellness app position on the UK Apple App Store, you can find out what your real biological age is, develop your longevity strategy, and get tips to rejuvenate yourself. Young.ai is a product of Deep Longevity company

?? Our March 26 online AMA guest star Alex Zhavoronkov was involved in developing Young.ai app. Make the most of the unique opportunity to meet Alex Zhavoronkov and to ask him questions! The event starts at 8 am PT/11 am ET on Friday! Register for the AMA here - https://lnkd.in/dHs77Qc

#sergeyyoung #longevity #LongevityMedicine #ama #ai

https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0318/2021031800510.pdf

NEWS RELEASE 16-MAR-2021
Physicians and scientists join forces to develop the longevity medicine curriculum
https://www.eurekalert.org/pub_releases/2021-03/dll-pas031521.php

Sanfull was driving the sp up to 20.9c with some large buys around 2pm. Volume picking up.
We were sold down from the 25-26c level on very low vol. Time for another leg up. Heimdal

VXR continue to rise. Up 51.5% today!
RPG hold 23,849,445 shares which are now valued at AU$11,900,000 @ 50c or
HK$71,500,000 which is 15.3% of Regent Pacific's MCap.
We are due for a lift!

Heimdal

Dougie, a fair bit of news to look forward to:

Confirmation of HK$25m from Wanbang (due any day now)
Confirmation of Macao launch (March)
Final 2020 results (March)
Confirmation of Taiwan launch (April)
Confirmation of China clinical trial start (April-May)
USA marketing study news (May)
Potential news on USA partner ahead of Phase III
Confirmation of USA Phase II study submission (first half of 2021)
News on Japan progress
News on OTC roll out in EU (June?)
Potential news on LATAM, India and Middle East commercial strategic partners
DLI market update
Potential new deal in the longevity sector?

Heimdal